Several recent science studies have claimed that the gut microbiome—the diverse array of bacteria that live in the stomach and intestines—may be to blame for obesity. But Katherine Pollard, PhD, a senior investigator at the Gladstone Institutes, says it is not that simple.
Dr. Pollard will be presenting at the Obesity and Microbiome symposium at the AAAS Annual Meeting in San Jose, CA on Friday, February 13, 2015 at 3:00 PM PT.
Using powerful computational tools, Dr. Pollard and her team have reanalyzed several previous studies and revealed that there is no significant relationship between body mass index (BMI) and the types of microbes in one’s gut. In fact, her lab found that there was greater variability in gut bacteria between the different studies than between the lean and obese individuals within each study.
Instead, Dr. Pollard thinks that it is the genetic make-up of the different strains of bacteria that is most important. This is because the DNA in bacteria can vary wildly. For example, while the genomes of two humans may only differ by 0.1%, two strains of the same bacteria can vary by to 30%—similar to the variation between human and mice genomes. What’s more, the differences in the bacterial genomes are often essential pieces that are involved in metabolism or the processing of sugar and fat.
Besides reflecting key functional changes in bacterial genomes, losses and gains of genes also affect genome size. When microbiomes are studied using metagenomics—sequencing their total DNA—differences in bacterial genome size can bias the estimation of the proportion of each gene in the sample. By developing a computational shortcut to rapidly estimate genome size using statistical modeling, Dr. Pollard’s team has been able to improve the accuracy of microbiome studies.
“It’s not enough to say what type of bacterial species are present, because that doesn’t tell you what they’re doing,” explains Dr. Pollard. “Since two strains of the same species can have such different genomes, you really need to know what genes are there and what role they play in order to link someone’s gut microbiota to BMI or disease.”
Gladstone researchers develop robust strategy for sifting through large-scale genetic data to better understand congenital heart problemsNews Release Research (Publication) Congenital Heart Disease Cardiovascular Disease Krogan Lab Pollard Lab Srivastava Lab Stem Cells/iPSCs
Two new studies underscore the importance of looking at bacterial strains when analyzing the human gut microbiomeNews Release Research (Publication) Data Science and Biotechnology Pollard Lab Big Data Microbiome
While the practice of placing papers on preprint servers ahead of peer review remains controversial in the scientific community worldwide, many Gladstone investigators are using bioRxiv to advance their research and get information out more quicklyGladstone Experts COVID-19 Krogan Lab McDevitt Lab Ott Lab Pollard Lab